163 related articles for article (PubMed ID: 32278009)
41. Isoliquiritigenin pretreatment attenuates cisplatin induced proximal tubular cells (LLC-PK1) death and enhances the toxicity induced by this drug in bladder cancer T24 cell line.
Patricia Moreno-Londoño A; Bello-Alvarez C; Pedraza-Chaverri J
Food Chem Toxicol; 2017 Nov; 109(Pt 1):143-154. PubMed ID: 28870684
[TBL] [Abstract][Full Text] [Related]
42. Polymorphic renal transporters and cisplatin's toxicity in urinary bladder cancer patients: current perspectives and future directions.
Selim MS; Kassem AB; El-Bassiouny NA; Salahuddin A; Abu El-Ela RY; Hamza MS
Med Oncol; 2023 Jan; 40(2):80. PubMed ID: 36650399
[TBL] [Abstract][Full Text] [Related]
43. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
44. [Advance in studies on molecular mechanisms of cisplatin resistance and intervention with traditional Chinese medicines].
Liu L; Bian K
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3216-20. PubMed ID: 25522600
[TBL] [Abstract][Full Text] [Related]
45. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid.
Hoffman AD; Engelstein D; Bogenrieder T; Papandreou CN; Steckelman E; Dave A; Motzer RJ; Dmitrovsky E; Albino AP; Nanus DM
Clin Cancer Res; 1996 Jun; 2(6):1077-82. PubMed ID: 9816270
[TBL] [Abstract][Full Text] [Related]
46. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
Kazmi SM; Plante RK; Visconti V; Lau CY
Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
[TBL] [Abstract][Full Text] [Related]
47. 4,4-Diisothiocyanatostilbene Disulfonic Acid Enhanced 15-Deoxy-Δ
Koma H; Yamamoto Y; Kumagai H; Yagami T
Biol Pharm Bull; 2019; 42(11):1913-1920. PubMed ID: 31685774
[TBL] [Abstract][Full Text] [Related]
48. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
49. Identification of 2',4',6'-Trihydroxyacetophenone as Promising Cysteine Conjugate Beta-Lyase Inhibitor for Preventing Cisplatin-Induced Nephrotoxicity.
Sukeda N; Fujigaki H; Ando T; Ando H; Yamamoto Y; Saito K
Mol Cancer Ther; 2023 Jun; ():OF1-OF9. PubMed ID: 37294883
[TBL] [Abstract][Full Text] [Related]
50. Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR-dependent gene expression.
Yang L; Munoz-Medellin D; Kim HT; Ostrowski J; Reczek P; Brown PH
Breast Cancer Res Treat; 1999 Aug; 56(3):277-91. PubMed ID: 10573118
[TBL] [Abstract][Full Text] [Related]
51. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines.
Xu XC; Liu X; Tahara E; Lippman SM; Lotan R
Cancer Res; 1999 May; 59(10):2477-83. PubMed ID: 10344761
[TBL] [Abstract][Full Text] [Related]
52. The cyclin-dependent kinase inhibitor AT7519 augments cisplatin's efficacy in ovarian cancer via multiple oncogenic signaling pathways.
Wang L; Chen Y; Li H; Xu Q; Liu R
Fundam Clin Pharmacol; 2022 Feb; 36(1):81-88. PubMed ID: 34212421
[TBL] [Abstract][Full Text] [Related]
53. Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration.
Iwakura T; Zhao Z; Marschner JA; Devarapu SK; Yasuda H; Anders HJ
Nephrol Dial Transplant; 2019 Oct; 34(10):1669-1680. PubMed ID: 30624740
[TBL] [Abstract][Full Text] [Related]
54. Identification of 2',4',6'-trihydroxyacetophenone as promising cysteine conjugate beta-lyase inhibitor for preventing cisplatin-induced nephrotoxicity.
Sukeda N; Fujigaki H; Ando T; Ando H; Yamamoto Y; Saito K
Mol Cancer Ther; 2023 May; ():. PubMed ID: 37163384
[TBL] [Abstract][Full Text] [Related]
55. Roles of volume-sensitive Cl- channel in cisplatin-induced apoptosis in human epidermoid cancer cells.
Ise T; Shimizu T; Lee EL; Inoue H; Kohno K; Okada Y
J Membr Biol; 2005 Jun; 205(3):139-45. PubMed ID: 16362502
[TBL] [Abstract][Full Text] [Related]
56. Retinoic acid as cause of cell proliferation or cell growth inhibition depending on activation of one of two different nuclear receptors.
Wolf G
Nutr Rev; 2008 Jan; 66(1):55-9. PubMed ID: 18254885
[TBL] [Abstract][Full Text] [Related]
57. Mutual regulation of hypoxic and retinoic acid related signalling in tubular proximal cells.
Fernández-Martínez AB; Jiménez MI; Hernández IS; García-Bermejo ML; Manzano VM; Fraile EA; de Lucio-Cazaña FJ
Int J Biochem Cell Biol; 2011 Aug; 43(8):1198-207. PubMed ID: 21554977
[TBL] [Abstract][Full Text] [Related]
58. Protection of cortical neurons against oxygen-glucose deprivation and N-methyl-D-aspartate by DIDS and SITS.
Tauskela JS; Mealing G; Comas T; Brunette E; Monette R; Small DL; Morley P
Eur J Pharmacol; 2003 Mar; 464(1):17-25. PubMed ID: 12600690
[TBL] [Abstract][Full Text] [Related]
59. Phosphorylation of eIF2α suppresses cisplatin-induced p53 activation and apoptosis by attenuating oxidative stress via ATF4-mediated HO-1 expression in human renal proximal tubular cells.
Ju SM; Jo YS; Jeon YM; Pae HO; Kang DG; Lee HS; Bae JS; Jeon BH
Int J Mol Med; 2017 Dec; 40(6):1957-1964. PubMed ID: 29039478
[TBL] [Abstract][Full Text] [Related]
60. Notch1 inhibition enhances DNA damage induced by cisplatin in cervical cancer.
Li S; Ren B; Shi Y; Gao H; Wang J; Xin Y; Huang B; Liao S; Yang Y; Xu Z; Li Y; Zeng Q
Exp Cell Res; 2019 Mar; 376(1):27-38. PubMed ID: 30690027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
